What is the significance of “analogous art” in determining enablement for chemical compounds?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. “Analogous art” plays a crucial role in determining enablement for…

Read More

What is the AIA 35 U.S.C. 102(b)(2)(A) exception?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The AIA 35 U.S.C. 102(b)(2)(A) exception is a provision in…

Read More

When does the AIA 35 U.S.C. 102(b)(2)(C) exception not remove a U.S. patent document as prior art?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The AIA 35 U.S.C. 102(b)(2)(C) exception does not always remove…

Read More

Can admissions be used as a basis for establishing a substantial new question of patentability in ex parte reexamination?

Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-29 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Admissions, per se, cannot be the sole basis for establishing…

Read More